These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17308287)

  • 1. Lowering the bleeding risk in intra-arterial thrombolysis without losing efficiency by excluding adjunctive heparin?
    Trouillas P
    J Neurol Neurosurg Psychiatry; 2007 Mar; 78(3):222-3. PubMed ID: 17308287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Principles underlying the use of conjunctive agents with plasminogen activators.
    Shebuski RJ
    Ann N Y Acad Sci; 1992 Dec; 667():382-94. PubMed ID: 1309058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Between thrombosis and bleeding - a case of paroxysmal nocturnal hemoglobinuria].
    Reinhart WH
    Ther Umsch; 2010 Dec; 67(12):609-12. PubMed ID: 21108185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are anticoagulants better than antiplatelet agents for treatment of acute ischemic stroke?
    Griffin G
    Am Fam Physician; 2003 Oct; 68(7):1307-8. PubMed ID: 14567484
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin as an adjuvant to thrombolytic therapy in acute myocardial infarction.
    Metz BK; Topol EJ
    Biomed Pharmacother; 1996; 50(6-7):243-53. PubMed ID: 8952863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy.
    Sarmiento A
    J Am Coll Surg; 2001 Oct; 193(4):465-6. PubMed ID: 11584979
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
    Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin and other antithrombotic agents in the setting of a primarily medical treatment of unstable coronary artery disease.
    Verheugt FW
    Haemostasis; 2000; 30 Suppl 2():122-7; discussion 106-7. PubMed ID: 11251355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acute ischemic stroke: where are we?
    Mohr JP; Hartmann A
    Neurologia; 1999 Jan; 14(1):6-10. PubMed ID: 10079685
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of the results of randomized trials on the tactics of management of patients with acute stroke].
    Warlow C
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(2):47-50. PubMed ID: 10081136
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
    Collins R; Peto R; Baigent C; Sleight P
    N Engl J Med; 1997 Mar; 336(12):847-60. PubMed ID: 9062095
    [No Abstract]   [Full Text] [Related]  

  • 12. [Follow up antithrombotic therapy after thrombolysis].
    Nakamura Y
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):825-31. PubMed ID: 12436623
    [No Abstract]   [Full Text] [Related]  

  • 13. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet therapy or low-dose heparin and neuraxial anaesthesia.
    Schneider MC; Caliezi C; Seeberger MD
    Acta Anaesthesiol Scand Suppl; 1997; 111():219-21. PubMed ID: 9421021
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advance of antithrombotic treatment in patients with cerebral microbleed.
    Chen Z; Ding Y; Ji X; Yin X; Meng R
    J Thromb Thrombolysis; 2021 Feb; 51(2):530-535. PubMed ID: 32632557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin augmentation of the efficacy of thrombolysis.
    O'Donnell CJ; Jonas MA; Hennekens CH
    Coron Artery Dis; 1995 Dec; 6(12):936-9. PubMed ID: 8723015
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of aspirin plus heparin with heparin alone on asymptomatic perioperative deep vein thrombosis in candidates for elective off-pump coronary artery bypass graft: a randomized clinical trial.
    Mirhosseini SJ; Forouzannia SK; Mostafavi Pour Manshadi SM; Ali-Hasan-Al-Saegh S; Naderi N; Sanatkar M
    Cardiol J; 2013; 20(2):139-43. PubMed ID: 23558871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced tissue factor pathway inhibitor-1 after pharmacological thrombolysis: an epiphenomenon or potential culprit in rethrombosis?
    Shah PK
    Circulation; 2002 Jan; 105(3):270-1. PubMed ID: 11804975
    [No Abstract]   [Full Text] [Related]  

  • 20. Aspirin after thrombolysis for MI.
    Seaton TL
    J Fam Pract; 1997 Mar; 44(3):249-50. PubMed ID: 9071241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.